# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
B of A Securities analyst Derik De Bruin maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price targe...
Wells Fargo analyst Brandon Couillard initiates coverage on Thermo Fisher Scientific (NYSE:TMO) with a Overweight rating and...
Henrietta Lacks' family sues Novartis and Viatris for profiting from her HeLa cells without consent. The lawsuit seeks prof...